PMC:7247521 / 23973-25288
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
335 | 995-999 | Gene | denotes | KEGG | |
336 | 1120-1124 | Disease | denotes | OMIN | |
337 | 1169-1172 | Disease | denotes | XCH | |
342 | 141-144 | Disease | denotes | XCH | |
343 | 334-337 | Disease | denotes | XCH | |
344 | 588-591 | Disease | denotes | XCH | |
345 | 779-787 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T276 | 308-317 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T277 | 752-757 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T278 | 779-787 | SP_7 | denotes | COVID-19 |
T279 | 937-946 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T280 | 1115-1118 | NCBITaxon:9606 | denotes | Man |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T69 | 424-432 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T70 | 495-503 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T71 | 563-571 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T72 | 632-640 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T73 | 705-713 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T58 | 779-787 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T162 | 542-544 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T163 | 789-790 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T164 | 1140-1141 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T165 | 1149-1150 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T137 | 49-52 | Chemical | denotes | TCM | http://purl.obolibrary.org/obo/CHEBI_145500 |
T138 | 424-432 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T139 | 495-503 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T140 | 563-571 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T141 | 632-640 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T142 | 705-713 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T143 | 752-757 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T144 | 926-928 | Chemical | denotes | ID | http://purl.obolibrary.org/obo/CHEBI_141439 |
T145 | 1050-1053 | Chemical | denotes | TTD | http://purl.obolibrary.org/obo/CHEBI_73659 |
T146 | 1115-1118 | Chemical | denotes | Man | http://purl.obolibrary.org/obo/CHEBI_37684 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T158 | 0-25 | Sentence | denotes | 3.4 Network construction |
T159 | 26-161 | Sentence | denotes | After using the BATMAN-TCM, we constructed five ingredients-target-pathway-disease networks, including MSXG, SGMH, XCH, WLS and Others. |
T160 | 162-378 | Sentence | denotes | In order to emphasize the important network elements, we showed the networks that exhibit those targets with larger than 6, 5, 8, 7 and 4 linking compounds for MSXG, SGMH, XCH, WLS and Others, respectively (Fig. 6 ). |
T161 | 379-729 | Sentence | denotes | MSXG network contained 31 key components, 50 proteins and 17 pathways; SGMH network contained 15 key components, 20 proteins and 8 pathways; WLS network contained 18 key components, 9 proteins and 4 pathways; XCH network contained 32 key components, 15 proteins and 12 pathways; Others network contained 10 key components, 13 proteins and 3 pathways. |
T162 | 730-847 | Sentence | denotes | To find the potential drugs of formulae QFPD for COVID-19, a total of 67 hub components were used for ADMET analysis. |
T163 | 848-900 | Sentence | denotes | Fig. 6 The component-target-pathway-disease network. |
T164 | 901-917 | Sentence | denotes | Purple polygons: |
T165 | 918-1020 | Sentence | denotes | PubChem ID of QFPD compounds; blue pentagrams: QFPD targets; yellow circles: KEGG pathway; red square: |
T166 | 1021-1082 | Sentence | denotes | Therapeutic Target Database (TTD) disease term, green square: |
T167 | 1083-1139 | Sentence | denotes | Online Mendelian Inheritance in Man (OMIN) disease term. |
T168 | 1140-1176 | Sentence | denotes | A: MXSG, B: SGMH, C: WLS, D: XCH, E: |
T169 | 1177-1315 | Sentence | denotes | Others. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) |